## Abstract Carbon‐11 labelled befloxatone ((5R)‐5‐(methoxymethyl)‐3‐[4‐[(3R)‐4,4,4‐trifluoro‐3‐hydroxybutoxy]phenyl]‐2‐oxazolidinone) is a reversible and selective monoamine oxidase‐A (MAO‐A) inhibitor and appears to be a new potent PET tracer for the __in vivo__ imaging of MAO‐A density. In this
In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter
✍ Scribed by Alin J. Severance; Matthew S. Milak; J. S. Dileep Kumar; Jaya Prabhakaran; Vattoly J. Majo; Norman R. Simpson; Ronald L. Van Heertum; Victoria Arango; J. John Mann; Ramin V. Parsey
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 262 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A convenient synthesis of [N‐methyl‐^11^C]‐3‐[(6‐dimethylamino)pyridin‐3‐yl]‐2,5‐dimethyl‐__N__,__N__‐dipropylpyrazolo[1,5‐a]pyrimidine‐7‐amine (R121920), a highly selective CRF~1~ antagonist has been developed as a potential PET ligand. 3 ‐ [(6 ‐ methylamino)pyridin ‐ 3 ‐ yl]‐2,5‐dimet
## Abstract Radiolabeled vesamicol analogs are promising candidates as ligands for the vesicular acetylcholine transporter (VAChT) to enable __in vivo__ imaging of early cholinergic degenerations in brain. The 4‐fluorobenzoyl‐substituted azaspirovesamicol derivative FBASV is one out of six novel ve
## Abstract Dopamine transporter (DAT) neuroimaging is a useful tool in Parkinson's disease diagnosis, staging and follow‐up providing information on the integrity of the dopaminergic neurotransmitter system __in vivo__. 4‐(2‐(Bis(4‐fluorophenyl)methoxy)ethyl)‐1‐(4‐iodobenzyl)piperidine (7) has nan